By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Why is it important to get your prostate checked after crossing 50? Expert explains how simple tests can help prevent cancer.

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

June is Men’s Health Month, so it seems appropriate to begin the month by focusing on a topic specific to men’s wellness and ...

Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation radiopharmaceuticals for the ...

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

In her forthcoming memoir, former First Lady Jill Biden candidly addresses former President Joe Biden's stage IV prostate ...

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

The largest real-world study ever conducted on prostate cancer in Brazil analyzed data from 670,205 patients treated through ...

With a new phase 3 win for Erleada (apalutamide), Johnson & Johnson is proposing a solution to a longstanding prostate cancer treatment gap. For patients with high-risk localized or locally advanced ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

Dr. Phillip Koo with the Prostate Cancer Foundation and Bill, who lives with prostate cancer, have all you need to know.